Clinical Trial Update: Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in Esophageal Squamous Cell Carcinoma evaluating a neoantigen-loaded dendritic cell vaccine, potentially in combination with immune che…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Neoantigen-loaded dendritic cell vaccine

Snippet

Sponsor: Sichuan University | Conditions: Esophageal Squamous Cell Carcinoma (ESCC), Neoantigen-loaded Dendritic Cell Vaccine | Phase 2 | Status: RECRUITING